<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000413948"><TermName>Genasense</TermName><TermPronunciation>(JEH-nuh-sents)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of cancer. It may kill cancer cells by blocking the production of a protein that makes cancer cells live longer and by making them more sensitive to anticancer drugs. It is a type of antisense oligodeoxyribonucleotide. Also called augmerosen, bcl-2 antisense oligodeoxynucleotide G3139,  and oblimersen sodium.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000713532" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Genasense&quot;" language="en" id="_3"/><MediaLink ref="CDR0000713531" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Genasense&quot;" language="es" id="_4"/><SpanishTermName>Genasense</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Puede destruir células cancerosas al impedir la producción de una proteína que las hace vivir durante más tiempo y al hacerlas más sensibles a los medicamentos contra el cáncer. Es un tipo de oligodesoxirribonucleótido no codificante. También se llama augmerosen, oblimersen sódico,  y oligodesoxinucleótido no codificante G3139 de bcl-2.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2005-05-23</DateFirstPublished><DateLastModified>2010-05-26</DateLastModified></GlossaryTerm>
